Growth Metrics

Myomo (MYO) Asset Writedowns and Impairment (2017 - 2025)

Myomo posted quarterly Asset Writedowns and Impairment of $103779.0 for Q3 2025, up 100.95% on a QoQ basis from $51643.0 in Q1 2025.

Myomo (MYO) has 8 years of Asset Writedowns and Impairment data on file, last reported at $103779.0 in Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $103779.0; the trailing twelve-month figure through Sep 2025 stood at $193822.0 (up 821.56% YoY), and the FY2024 full-year result was $43657.0, up 53.72% from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 stood at $103779.0, up from $51643.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $103779.0 in Q3 2025 and bottomed at -$374.0 in Q3 2023.
  • The 4-year median for Asset Writedowns and Impairment is $20925.0 (2022), against an average of $31694.4.
  • The widest annual swing landed in 2023, when Asset Writedowns and Impairment tumbled 50.14%; it then soared 143.42% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $26075.0 in 2022, then slumped by 39.5% to $15775.0 in 2023, then jumped by 143.42% to $38400.0 in 2024, then soared by 170.26% to $103779.0 in 2025.
  • The last three Asset Writedowns and Impairment figures came in at $103779.0 (Q3 2025), $51643.0 (Q1 2025), and $38400.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 103,779.00
Sep 30, 2025 103,779.00
Mar 31, 2025 51,643.00
Mar 31, 2025 51,643.00
Dec 31, 2024 38,400.00
Dec 31, 2024 38,400.00
Jun 30, 2024 5,257.00
Jun 30, 2024 5,257.00
Dec 31, 2023 15,775.00
Dec 31, 2023 15,775.00
Sep 30, 2023 -374.00
Sep 30, 2023 -374.00
Mar 31, 2023 13,000.00
Mar 31, 2023 13,000.00
Mar 31, 2022 26,075.00
Mar 31, 2022 26,075.00
Dec 31, 2020 -20,000.00
Dec 31, 2020 -20,000.00
Sep 30, 2020 -16,000.00
Sep 30, 2020 -16,000.00
Jun 30, 2020 21,839.00
Jun 30, 2020 21,839.00
Mar 31, 2020 24,000.00
Mar 31, 2020 24,000.00
Mar 31, 2019 16,275.00
Mar 31, 2019 16,275.00
Dec 31, 2018 6,000.00
Dec 31, 2018 6,000.00
Sep 30, 2018 -2,242.00
Sep 30, 2018 -2,242.00
Jun 30, 2018 29,532.00
Jun 30, 2018 29,532.00
Mar 31, 2018 -645.00
Mar 31, 2018 -645.00
Dec 31, 2017 11,400.00
Dec 31, 2017 11,400.00
Sep 30, 2017 -5,073.00
Sep 30, 2017 -5,073.00
Jun 30, 2017 7,509.00
Jun 30, 2017 7,509.00
Mar 31, 2017 28,519.00
Mar 31, 2017 28,519.00